Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 27.07.2026 1 AJNR Am J Neuroradiol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 11 J Neurooncol 1 J Neuropathol Exp Neurol 1 J Neurosurg 4 Neuro Oncol 1 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJNR Am J Neuroradiol

1. SALL C, Salomonsson T, Grubor I, Saenz Sarda X, et al
   Mapping fluid-suppressed diffusivity in brain tumors.
   AJNR Am J Neuroradiol. 2026 Jul 24:ajnr.A9545. doi: 10.3174/ajnr.A9545.
   PubMed         Abstract available
   
   

   
   Int J Cancer

2. WANG H, Li J, Cao L, Zhang Y, et al
   Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.
   Int J Cancer. 2026 Apr 18. doi: 10.1002/ijc.70507.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

3. PERLOW HK, Dawson EL, Sun Y, Yu J, et al
   Early Integrated Neuropsychological Care for Patients with Brain Metastases: A Randomized Controlled Trial (ATHENA Trial).
   Int J Radiat Oncol Biol Phys. 2026 Jul 18:S0360-3016(26)04025.
   PubMed         Abstract available
   
   

   
   J Clin Oncol

4. LIANG B, Weil M
   Corticosteroids in Glioblastoma Management: A Reconsideration of a 65-Year Practice.
   J Clin Oncol. 2026 Jul 22:JCO2600191. doi: 10.1200/JCO-26-00191.
   PubMed        
   
   

   
   J Neurooncol

5. KINGER S, Sedor G, Buss EJ, Giannaris E, et al
   Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes.
   J Neurooncol. 2026;179:4.
   PubMed         Abstract available
   
   
6. MAATTA J, Laajava J, Niemela M, Korja M, et al
   Declining age-adjusted surgical incidence of intracranial meningiomas: a 19-year retrospective analysis from an academic hospital.
   J Neurooncol. 2026;179:6.
   PubMed         Abstract available
   
   
7. XING J, Feinaj A, Ritter Z, Clarke K, et al
   Spatial distribution and prognostic significance of hemorrhagic imaging features in brain metastases from metastatic renal cell carcinoma.
   J Neurooncol. 2026;179:5.
   PubMed         Abstract available
   
   
8. ZHU Y, Yu S, Du B, Yao N, et al
   The persistent benefit of chemotherapy in elderly lung adenocarcinoma patients with brain metastases in the immunotherapy era.
   J Neurooncol. 2026;179:7.
   PubMed         Abstract available
   
   
9. MARCHAL J, Ybert L, Ducloie M, Geffrelot J, et al
   The threefold value of surgery in previously irradiated brain metastases.
   J Neurooncol. 2026;179:8.
   PubMed         Abstract available
   
   
10. WOJTON-DZIEWONSKA D, Skora T, Aniol J, Popow-Gierba A, et al
    Survival, late toxicity and ability to return to work after proton radiotherapy for low-grade gliomas.
    J Neurooncol. 2026;179:9.
    PubMed         Abstract available
    
    
11. MUSTAFA MA, Hannan CJ, Amoo M, Sokan J, et al
    Derivation of a data-driven follow-up protocol for resected skull base meningiomas: a Bayesian analysis.
    J Neurooncol. 2026;179:11.
    PubMed         Abstract available
    
    
12. DREWES NB, Koutah L, Jain R, Carnduff J, et al
    Extent of resection and survival in IDH-wildtype glioblastoma: interaction with MGMT status and chemoradiation.
    J Neurooncol. 2026;179:10.
    PubMed         Abstract available
    
    
13. CARRIERE PP, Haisraely O, Aaroe A, Ahmed K, et al
    Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology.
    J Neurooncol. 2026;179:12.
    PubMed         Abstract available
    
    
14. SANDERSON E, Drummond K, Dowling A, Bennett I, et al
    Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.
    J Neurooncol. 2026;179:13.
    PubMed         Abstract available
    
    
15. ZHU JW, Fernandes I, Lopes JB, Moravan V, et al
    Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy.
    J Neurooncol. 2026;179:14.
    PubMed         Abstract available
    
    

    
    J Neuropathol Exp Neurol

16. DE MENDONCA FERNANDES GM, Wu KC, Palmer J, Carrau R, et al
    NICO Myriad Automated Preservation System improves meningioma sample quality for molecular pathology assays.
    J Neuropathol Exp Neurol. 2026 Jul 20:nlag030. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Neurosurg

17. FABIANO AJ
    Letter to the Editor. The utility of biopsy prior to craniotomy in high-grade glioma.
    J Neurosurg. 2026 Jul 24:1-2. doi: 10.3171/2026.2.JNS26270.
    PubMed        
    
    

    
    Neuro Oncol

18. FILIBERTI S, Tavani C, Somenza E, Tassone N, et al
    A PTX3/TLR4 axis sustains SHH-Medulloblastoma growth and defines a new therapeutic vulnerability.
    Neuro Oncol. 2026 Jul 23:noag167. doi: 10.1093.
    PubMed         Abstract available
    
    
19. LAU BC, Ajaero DP, Hoff BA, Pearson A, et al
    Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma.
    Neuro Oncol. 2026 Jul 21:noag164. doi: 10.1093.
    PubMed         Abstract available
    
    
20. HAN S, Kim Y, Kim S, Lee C, et al
    Programmable microfluidic modeling of the glioblastoma immune microenvironment recapitulates temporally regulated tumor-immune signaling.
    Neuro Oncol. 2026 Jul 21:noag151. doi: 10.1093.
    PubMed         Abstract available
    
    
21. KINSLOW CJ, Schiff D
    Mature Results from EORTC 22033: Implications of Inferior Results with Monotherapy for Grade 2 Gliomas.
    Neuro Oncol. 2026 Jul 20:noag162. doi: 10.1093.
    PubMed        
    
    

    
    PLoS One

22. YANG J, Kollings J, Idnani E, Wilson DR, et al
    Engineering of episomal plasmid structure to enhance non-viral Poly(beta-amino ester) nanoparticle gene delivery to liver and brain cancer cells.
    PLoS One. 2026;21:e0352468.
    PubMed         Abstract available
    
    

    
    Radiology

23. HOCH MR, Breza VR, Miller GW, Price RJ, et al
    Quantitative Susceptibility Mapping Shows Size-dependent Focused Ultrasound-mediated Therapeutic Delivery to Naive Brain and Gliomas in Mice.
    Radiology. 2026;320:e251005.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum